SCOTTISH scientists are part of a team hoping to develop virus-loaded capsules that will target a hospital superbug if swallowed by infected patients.

The researchers from Glasgow University and Leicester University say their work could lead to an alternative to antibiotics to treat Clostridium difficile.

Scientists isolated a family of bacteriophages -viruses that target bacteria -which destroy C diff strains. Laboratory tests show the "phages" are effective against 90% of bugs that cause hospital infections.

Lead scientist Dr Martha Clokie, from the University of Leicester, said: "Ever since the discovery of penicillin, antibiotics have been heralded as the 'silver bullets' of medicine. They have saved countless lives and impacted on the well-being of humanity.

"But less than a century following their discovery, the future impact of antibiotics is dwindling at a pace that no-one anticipated, with more and more bacteria out-smarting and 'out-evolving' these miracle drugs. This has re-energised the search for new treatments."

The work, mainly funded by the Medical Research Council, has been conducted in conjunction with scientists from the University of Glasgow and the US company AmpliPhi Biosciences Corporation.

The goal is to prepare a "cocktail" of C diff phages suitable for patient trials. including establishing production, storage and delivery systems.

Around 40 viruses that target C diff strains have been identified so far. They are the subject of patent applications by the University of Leicester.